Moral distress: its manifestations in healthy donors during peripheral blood hematopoietic stem cell harvesting

In the 1980s, the number of allogeneic hematopoietic stem cell transplantations (allo-HSCTs) performed was low; however, at the end of the 1990s, a sustained increase was observed. In 2016, 8539 cases of allo-HSCT were reported by the Center for International Blood and Marrow Transplant Research (CIBMTR) (1). Many changes have occurred for the benefit of patients receiving an allo-HSCT, such as better antibiotics, antifungals and immunosuppressants. In the area of hematopoietic cell donors, however, there have been few changes throughout this time.

Source: Biology of Blood and Marrow Transplantation - June 11, 2021 Category: Hematology Authors: Cesar H. Guti érrez-Aguirre, José C. Jaime-Pérez, Fernando de la Garza-Salazar, Geraldina Guerrero-González, Abel Guzmán-López, Guillermo J. Ruiz-Arguelles, David Gómez-Almaguer, Olga G. Cantú-Rodríguez Source Type: research